Metraipolis › archive › dc_d7af075ec53b
Dopamine D2/3R availability after discontinuation of antipsychotic treatment: a [11C]raclopride PET study in remitted first-episode psychosis patients — Europe PMC PMID:40916717
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40916717
- DOI
- 10.1017/s003329172510161x
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T02:16:44.265Z
- SHA-256 of the archived text
0f29f135780f662f9544c869e22fcca78c27b4458dffd8304dfbddab123febcb- Stable URL of this page
https://metraipolis.com/documento/dc_d7af075ec53b
How to cite
Dopamine D2/3R availability after discontinuation of antipsychotic treatment: a [11C]raclopride PET study in remitted first-episode psychosis patients — Europe PMC PMID:40916717 — Europe PMC (en), https://europepmc.org/article/MED/40916717 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d7af075ec53b (Metraipolis archive dc_d7af075ec53b, sha256 0f29f135780f662f9544c869e22fcca78c27b4458dffd8304dfbddab123febcb)
BibTeX
@misc{dcd7af075ec53b,
title = {Dopamine D2/3R availability after discontinuation of antipsychotic treatment: a [11C]raclopride PET study in remitted first-episode psychosis patients — Europe PMC PMID:40916717},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40916717},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d7af075ec53b; sha256 0f29f135780f662f9544c869e22fcca78c27b4458dffd8304dfbddab123febcb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40916717. Agents can read the archived copy with the MCP tool read_document.